SARS-Cov-2 Test Quality Guide / Report

Case Study

At a glance

Cluster
Sanatate
Type of problem

Advocacy

Product

Community Access Pro

The CLIENT

Industry

Pharmaceutical Industry

Turnover (EUR)

58000000000

Number of Employees

98000

One of the global pioneers of the pharmaceutical and diagnostic industry.

The CASE

Issue

There is confusion at European level in the ECDC Test Guide regarding the use of the term antigen test, rapid test, laboratory test. The ECDC definition of what an antigen test entails does not include the possibility of it being used and reported as a result. The client wants to clarify this aspect, from the European guide.

Our Solution

Professional debate on “Possibilities to increase the quality of testing and optimize the time to diagnosis in Sars-Cov-2 infection”, to identify gaps in the EDCD test guide and ways to correct them.

Implementation

1 Advisory Board with public health experts, specialists in infectious diseases, microbiologists, laboratory representatives

1 Report produced during the program, sent to health authorities and the press

Marketing & Communication Toolbox

The Partner was advertised on the invitation and all communication materials related to the program;

The topics from the debates were established together with the Partner;

Representatives of the Partner attended debate;

All guests and attendees were chosen after consultations with the Partner.

Results

1 Advisory Board;

10 attendees;

1 document with the identified problems and solutions was prepared and sent to the authorities

Timing & Budget

Start Date

apr. 2021

End Date

apr. 2021

Budget (EUR)

950

Communities